fbpx
QQQ
+ 5.37
298.74
+ 1.76%
DIA
+ 5.88
303.77
+ 1.9%
SPY
+ 7.57
369.16
+ 2.01%
TLT
+ 0.17
138.47
+ 0.12%
GLD
+ 0.10
158.97
+ 0.06%

SOL Global's HeavenlyRx To Acquire Airganics

July 9, 2019 12:15 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
SOL Global's HeavenlyRx To Acquire Airganics

HeavenlyRx, a portfolio company of SOL Global Investments Corp (OTC:SOLCF), has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million. 

The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.

Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.

All brands are focused to capture the CBD wellness space and already have distribution channels. 

Related Links:

Discussing Sol Global's $30M Hemp Biomass Investment With CEO Brady Cobb

OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles

Posted-In:

Cannabis M&A News Markets